CCR4 antagonist 3-1
Modify Date: 2024-04-03 12:17:18
CCR4 antagonist 3-1 structure
|
Common Name | CCR4 antagonist 3-1 | ||
|---|---|---|---|---|
| CAS Number | 1957-01-3 | Molecular Weight | 240.32 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C14H12N2S | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of CCR4 antagonist 3-1CCR4 antagonist 3 is a potent chemokine receptor 4 (CCR4) antagonist with an IC50 value of 1.7 μM for [125I]TARC (thymus and activation regulated chemokine). CCR4 antagonist 3 inhibits binding of radiolabeled TARC and macrophage-derived chemokine (MDC) to CCR4 receptors on the surface of CEM cells. CCR4 antagonist 3 also inhibits the in vitro migration of CEM cells mediated by TARC (IC50 = 6.4 μM)[1]. |
| Name | CCR4 antagonist 3-1 |
|---|
| Description | CCR4 antagonist 3 is a potent chemokine receptor 4 (CCR4) antagonist with an IC50 value of 1.7 μM for [125I]TARC (thymus and activation regulated chemokine). CCR4 antagonist 3 inhibits binding of radiolabeled TARC and macrophage-derived chemokine (MDC) to CCR4 receptors on the surface of CEM cells. CCR4 antagonist 3 also inhibits the in vitro migration of CEM cells mediated by TARC (IC50 = 6.4 μM)[1]. |
|---|---|
| Related Catalog | |
| Target |
CCR4 [125I]-TARC-CCR4:1.7 μM (IC50) |
| In Vivo | CCR4 antagonist 3 (compound 1) (0.5 mg/kg for IV; 2 mg/kg for PO; single dosage) exhibits a high clearance, short half-life and low oral bioavailability[1]. Animal Model: Rats[1] Dosage: 0.5 mg/kg for IV; 2 mg/kg for PO Administration: IV and PO; single dosage Result: Exhibited a high clearance of 4.2 L/h/kg and a short half-life of 0.4 h, and the oral bioavailability of 2%. |
| References |
| Molecular Formula | C14H12N2S |
|---|---|
| Molecular Weight | 240.32 |